Paper · 9841584
Benefits of colonoscopic surveillance and prophylactic colectomy in patients with hereditary nonpolyposis colorectal cancer mutations.
Syngal S and 4 others. Ann Intern Med, 1998. Cited by 132 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Benefits of colonoscopic surveillance and prophylactic colectomy in patients with hereditary nonpolyposis colorectal cancer mutations. Papers, record 9841584. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9841584
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Colectomy | Major topic |
| Colonoscopy | Major topic |
| Colorectal Neoplasms, Hereditary Nonpolyposis | Major topic |
| Proctocolectomy, Restorative | Major topic |
| Adult | |
| Aged | |
| Anastomosis, Surgical | |
| Decision Support Techniques | |
| Heterozygote | |
| Humans | |
| Ileum | |
| Life Expectancy | |
| Markov Chains | |
| Middle Aged | |
| Mutation | |
| Quality-Adjusted Life Years | |
| Rectum | |
| Sensitivity and Specificity |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 5R25CA57711 | NCI NIH HHS | United States | R25CA057711 | PubMed and NIH |
Source NIH RePORTER
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References0
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
None in this release.
Cited by43
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 132 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40,292,001 | Hereditary Colorectal Cancer: From Diagnosis to Surgical Options. | Clin Colon Rectal Surg | 2025 | https://conductscience.org/library/papers/40292001 | PubMed |
| 39,859,102 | Lynch Syndrome-Impact of the Type of Deficient Mismatch Repair Gene Mutation on Diagnosis, Clinical Presentation, Surveillance and Therapeutic Approaches. | Medicina (Kaunas) | 2025 | https://conductscience.org/library/papers/39859102 | PubMed |
| 33,746,161 | Interval between the First Cancer and the Genetic Diagnosis in Lynch Syndrome Probands. | Intern Med | 2021 | https://conductscience.org/library/papers/33746161 | PubMed |
| 31,880,776 | Fertility Impact of Initial Operation Type for Female Ulcerative Colitis Patients. | Inflamm Bowel Dis | 2020 | https://conductscience.org/library/papers/31880776 | PubMed |
| 29,071,502 | Phenotypic and genotypic heterogeneity of Lynch syndrome: a complex diagnostic challenge. | Fam Cancer | 2018 | https://conductscience.org/library/papers/29071502 | PubMed |
| 28,752,083 | Recognition of Lynch Syndrome Amongst Newly Diagnosed Colorectal Cancers at St. Paul's Hospital. | Can J Gastroenterol Hepatol | 2017 | https://conductscience.org/library/papers/28752083 | PubMed |
| 28,391,421 | The Rising Incidence of Younger Patients With Colorectal Cancer: Questions About Screening, Biology, and Treatment. | Curr Treat Options Oncol | 2017 | https://conductscience.org/library/papers/28391421 | PubMed |
| 27,541,298 | Systematic review of health state utility values for economic evaluation of colorectal cancer. | Health Econ Rev | 2016 | https://conductscience.org/library/papers/27541298 | PubMed |
| 27,314,187 | The Experience of Extended Bowel Resection in Individuals With a High Metachronous Colorectal Cancer Risk: A Qualitative Study. | Oncol Nurs Forum | 2016 | https://conductscience.org/library/papers/27314187 | PubMed |
| 26,938,782 | Cost-effectiveness of routine screening for Lynch syndrome in colorectal cancer patients up to 70 years of age. | Genet Med | 2016 | https://conductscience.org/library/papers/26938782 | PubMed |
1 to 10 of 43
See all 43 cited byGenes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9841584
GET https://conductscience.org/api/papers/v1/9841584/cited_by?page=2